Published in J Appl Physiol Respir Environ Exerc Physiol on March 01, 1983
Nocturnal asthma: mechanisms and treatment. Br Med J (Clin Res Ed) (1984) 1.06
Night cough and general practice research. J R Coll Gen Pract (1986) 0.96
Effect of sleep stage on breathing in children with central hypoventilation. J Appl Physiol (1985) (2008) 0.89
Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms. Compr Physiol (2016) 0.78
Sleep breathing disorders and nocturnal respiratory pattern in patients with glycogenosis type II. Acta Myol (2014) 0.75
Respiratory rate variability in sleeping adults without obstructive sleep apnea. Physiol Rep (2016) 0.75
Microgravity alters respiratory abdominal and rib cage motion during sleep. J Appl Physiol (1985) (2009) 0.75
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Management of asthma: a consensus statement. Arch Dis Child (1989) 7.04
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38
Bronchial reactivity in cystic fibrosis. Pediatrics (1978) 2.70
Standards of pulmonary function in children. Am Rev Respir Dis (1969) 2.56
Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. J Pediatr (1981) 2.41
Pulmonary function abnormalities in symptom-free children after bronchiolitis. Pediatrics (1977) 2.32
Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med (1984) 2.22
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet (1987) 2.05
The complete nucleotide sequence of the ilvGMEDA operon of Escherichia coli K-12. Nucleic Acids Res (1987) 2.04
Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03
Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics (1981) 2.00
Ultrastructure of airways in children with asthma. Histopathology (1978) 1.97
Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology (1974) 1.95
Hepatic abscess and cystic fibrosis. Postgrad Med J (1988) 1.77
Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae. Microbiol Rev (1996) 1.77
Role of conventional physiotherapy in cystic fibrosis. J Pediatr (1988) 1.75
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66
Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics (1990) 1.65
Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64
Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr (1981) 1.62
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Clinical and physiological assessment of asthmatic children treated with beclomethasone dipropionate. J Allergy Clin Immunol (1976) 1.59
Nam1p, a protein involved in RNA processing and translation, is coupled to transcription through an interaction with yeast mitochondrial RNA polymerase. J Biol Chem (2000) 1.58
Transit time analysis of the forced expiratory vital capacity in cystic fibrosis. Am Rev Respir Dis (1976) 1.58
Genetic profile of gliosarcomas. Am J Pathol (2000) 1.57
Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr (1995) 1.56
Effects of respiration on cardiac performance. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.55
Severe acute asthma in a pediatric intensive care unit: six years' experience. Pediatrics (1989) 1.54
Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol (1999) 1.54
Passive respiratory mechanics in newborns and children. Am Rev Respir Dis (1984) 1.53
Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics. Am Rev Respir Dis (1974) 1.53
Malignant chest wall neoplasms of bone and cartilage: a pictorial review of CT and MR findings. Br J Radiol (2006) 1.52
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med (1985) 1.52
Pulmonary function in children with asthma at acute attack and symptom-free status. Am Rev Respir Dis (1969) 1.52
The approach to chronic cough in childhood. Ann Allergy (1988) 1.51
Mucociliary tracheal transport rates in man. J Appl Physiol (1975) 1.50
Lung function in children following repair of tracheoesophageal fistula. J Pediatr (1979) 1.46
Airway closure in children. J Appl Physiol (1972) 1.45
Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45
SURVEY AND SUMMARY: Saccharomyces cerevisiae basic helix-loop-helix proteins regulate diverse biological processes. Nucleic Acids Res (2000) 1.45
Childhood asthma: a rational approach to treatment. Ann Allergy (1990) 1.44
Spacers in childhood asthma--is there one for all occasions? Ann Allergy (1990) 1.43
The effect of single-dose and continuous skeletal muscle paralysis on respiratory system compliance in paediatric intensive care patients. Intensive Care Med (1996) 1.43
Maximal expiratory flows generated by rapid chest compression following end-inspiratory occlusion or expiratory clamping in young children. Eur Respir J (1995) 1.41
[Surfactant replacement therapy: a multicentric trial comparing two dosage approaches]. J Pediatr (Rio J) (2003) 1.40
Transcutaneous monitoring of oxygenation: what is normal? J Pediatr (1986) 1.37
Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37
Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.36
Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol (1985) (1987) 1.36
The open lung during small tidal volume ventilation: concepts of recruitment and "optimal" positive end-expiratory pressure. Crit Care Med (1999) 1.35
Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr (1985) 1.35
Sodium cromoglycate-induced changes in the dose-response curve of inhaled methacholine and histamine in asthmatic children. Am Rev Respir Dis (1979) 1.35
Ventilation by high-frequency oscillation in humans. Anesth Analg (1980) 1.35
Intermittent positive pressure respiration as a treatment in severe respiratory distress syndrome. Arch Dis Child (1965) 1.34
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33
The response to exercise in normal and asthmatic children. J Pediatr (1978) 1.32
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31
Retinal hemorrhage at high altitude. N Engl J Med (1970) 1.31
High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics (1989) 1.30
Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience-induced changes in hippocampal glucocorticoid receptor mRNA. Endocrinology (2001) 1.30
Pulmonary function in infants and children following the acute neonatal respiratory distress syndrome. Bull Physiopathol Respir (Nancy) (1974) 1.30
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br J Cancer (2009) 1.30
Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr (1993) 1.30
Early detection of pulmonary function abnormalities in cystic fibrosis. Pediatrics (1972) 1.29
Ventilation by high-frequency oscillation. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.29
Autoregulated expression of the yeast INO2 and INO4 helix-loop-helix activator genes effects cooperative regulation on their target genes. Mol Cell Biol (1995) 1.28
Acute asthma: observations regarding the management of a pediatric emergency room. Pediatrics (1989) 1.27
Control of acute mountain sickness. Aerosp Med (1971) 1.27
Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.26
Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis. Am Rev Respir Dis (1977) 1.26
Alpha 1 antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. Am J Med (1973) 1.26
Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis (1984) 1.26
Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Pediatr (1985) 1.25
Relative sensitivity of methods for measuring airway resistance in asthmatic children. Ann Allergy (1969) 1.25
A comparison of infra-red and convective heating for newborn infants. Lancet (1966) 1.25
Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy. Am Rev Respir Dis (1976) 1.24
Chronic illness in infancy and parenting stress: a comparison of three groups of parents. J Pediatr Psychol (1990) 1.24
Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23
Conference on the scientific basis of respiratory therapy. Pulmonary physiotherapy in the pediatric age group. Comments of a devil's advocate. Am Rev Respir Dis (1974) 1.22
The yeast UME6 gene is required for both negative and positive transcriptional regulation of phospholipid biosynthetic gene expression. Nucleic Acids Res (1996) 1.22
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet (1992) 1.22
Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr Pulmonol (1998) 1.22